Artiva Biotherapeutics’ (ARTV) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a report released on Tuesday morning,Benzinga reports. They currently have a $23.00 price objective on the stock. ARTV has been the topic of several other research reports. Wedbush reiterated an “outperform” rating and set a $18.00 price […]
Needham & Company LLC reissued their buy rating on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a report released on Tuesday morning,Benzinga reports. They currently have a $23.00 price objective on the stock. ARTV has been the topic of several other research reports. Wedbush reiterated an “outperform” rating and set a $18.00 price […]